These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 5624888)

  • 1. [Metabolism in Wilson's disease. Whole body counting of 64Cu].
    Terao T; Nakao K; Ogihara K; Mozai T; Nagai T
    Igaku To Seibutsugaku; 1967 Jun; 74(6):304-8. PubMed ID: 5624888
    [No Abstract]   [Full Text] [Related]  

  • 2. The pattern of the whole body distribution of radioactive copper (67Cu, 64Cu) in Wilson's Disease and various control groups.
    Walshe JM; Potter G
    Q J Med; 1977 Oct; 46(184):445-62. PubMed ID: 413153
    [No Abstract]   [Full Text] [Related]  

  • 3. Studies with radiocopper (64Cu) in Wilson's disease: dynamics of copper transport.
    Osborn SB; Walshe JM
    Clin Sci; 1965 Dec; 29(3):575-81. PubMed ID: 5848709
    [No Abstract]   [Full Text] [Related]  

  • 4. Study of copper metabolism in kinky hair disease (Menkes' disease) and in hepatolenticular degeneration (Wilson's disease) utilizing 67Cu and radioactivity counting in the total body and various tissues.
    Dekaban AS; O'Reilly S; Aamodt R; Rumble WF
    Trans Am Neurol Assoc; 1974; 99():106-9. PubMed ID: 4219083
    [No Abstract]   [Full Text] [Related]  

  • 5. Use of whole-body counter to study body retention of radiocopper in Wilson's disease.
    Hamamoto K; Tauxe WN; Novak LP; Goldstein NP
    J Lab Clin Med; 1968 Nov; 72(5):754-9. PubMed ID: 5697385
    [No Abstract]   [Full Text] [Related]  

  • 6. [3 cases of Wilson's disease in adults, with special reference to copper metabolism screening with 64Cu].
    Yoshida K; Noguchi S; Suzuki M; Nishitani H; Fukase M
    Rinsho Shinkeigaku; 1976 Jul; 16(7):529-35. PubMed ID: 986923
    [No Abstract]   [Full Text] [Related]  

  • 7. Copper dynamics in Wilson's disease.
    Osborn SB; Walshe JM; Williams R
    Ann Biol Clin (Paris); 1972; 30(4):391-6. PubMed ID: 5082973
    [No Abstract]   [Full Text] [Related]  

  • 8. Lysosomal defect of hepatic copper excretion in Wilson's disease (hepatolenticular degeneration).
    Sternlieb I; Van den Hamer CJ; Morell AG; Alpert S; Gregoriadis G; Scheinberg IH
    Gastroenterology; 1973 Jan; 64(1):99-105. PubMed ID: 4683859
    [No Abstract]   [Full Text] [Related]  

  • 9. Copper metabolism in Wilson's disease.
    WINTROBE MM; CARTWRIGHT GE; HODGES RE; GUBLER CJ; MAHONEY JP; DAUM K; BEAN WB
    Trans Assoc Am Physicians; 1954; 67():232-41. PubMed ID: 13216832
    [No Abstract]   [Full Text] [Related]  

  • 10. Body retention of injected 67Cu in patients with homozygous or heterozygous Wilson's disease and in normal subjects. Comparison of whole-body counting systems.
    Tauxe WN; Willvonseder R; Goldstein NP
    Mayo Clin Proc; 1974 Jun; 49(6):382-6. PubMed ID: 4209105
    [No Abstract]   [Full Text] [Related]  

  • 11. Studies with radioactive copper (64Cu and 67Cu): abdominal scintiscans in patients with Wilson's disease.
    Osborn SB; Szaz KF; Walshe JM
    Q J Med; 1969 Oct; 38(152):467-74. PubMed ID: 5355538
    [No Abstract]   [Full Text] [Related]  

  • 12. [Radioactive copper in the diagnosis of Wilson's disease].
    Czlonkowska A; Wehr H; Galewicz A; Harmak E; Rodo M; Wald I
    Pol Tyg Lek; 1973 May; 28(17):597-9. PubMed ID: 4712325
    [No Abstract]   [Full Text] [Related]  

  • 13. A critical evaluation of copper metabolism in Indian Wilson's disease children with special reference to their phenotypes and relatives.
    Prasad R; Kaur G; Walia BN
    Biol Trace Elem Res; 1998 Nov; 65(2):153-65. PubMed ID: 9881519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathogenesis of hepatocerebral disease. II. Histochemical study of copper of liver and brain in Wilson's disease.
    OKINAKA S; YOSHIKAWA M; TOYODA M; MOZAI T; TOYOKURA Y; KAMEYAMA M
    AMA Arch Neurol Psychiatry; 1954 Nov; 72(5):573-8. PubMed ID: 13206477
    [No Abstract]   [Full Text] [Related]  

  • 15. [Copper level and metallothionein-like Cu-binding protein in cultured skin fibroblasts from patients with Menkes' disease and Wilson's disease].
    Sato M; Hayashi A; Ito H; Tojo M; Arima M
    No To Shinkei; 1984 Nov; 36(11):1063-8. PubMed ID: 6525319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of the stable isotope 65Cu test for the screening of Wilson's disease in a family with two affected members.
    Merli M; Patriarca M; Loudianos G; Valente C; Riggio O; De Felice G; Petrucci F; Caroli S; Attili AF
    Ital J Gastroenterol Hepatol; 1998 Jun; 30(3):270-5. PubMed ID: 9759594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Wilson's disease: a new gene and an animal model for an old disease.
    Cuthbert JA
    J Investig Med; 1995 Aug; 43(4):323-36. PubMed ID: 7552582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of the heterozygote of Wilson's disease.
    O'Reilly S; Weber P; Pollycove M; Shipley L
    J Nucl Med; 1969 Mar; 10(3):143-4. PubMed ID: 5785018
    [No Abstract]   [Full Text] [Related]  

  • 19. The kinetics of copper uptake by the liver in Wilson's disease studied by a whole-body counter and a double labelling technique.
    Günther K; Lössner V; Lössner J; Biesold D
    Eur Neurol; 1975; 13(5):385-94. PubMed ID: 808415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intrahepatocellular localization of copper in Wilson's disease.
    Yano M; Sakamoto N; Takikawa T; Hayashi H
    Nagoya J Med Sci; 1993 Mar; 55(1-4):131-7. PubMed ID: 8247102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.